2024 | | Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis | 예영민 |
2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2024 | | Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies | 예영민 |
2024 | | CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria | 예영민 |
2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
2023 | | Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor | 강호철, 박해심, 신민경, 예영민, 조중현, 최보윤 |
2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
2023 | | Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study | 예영민 |
2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 예영민, 이영수 |
2023 | | Treatment with biological products for chronic urticaria | 예영민 |
2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines | 박해심, 신유섭, 예영민 |
2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2023 | | Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy | 예영민 |
2023 | | Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease | 박해심, 예영민 |
2023 | | Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry | 예영민 |
2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |